SMTL ID : 6xa9.3 (2 other biounits)

SARS CoV-2 PLpro in complex with ISG15 C-terminal domain propargylamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

hetero-1-1-mer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.192, C.195, C.227, C.229 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.192, A:C.195, A:C.227, A:C.229

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 2 residues within 4Å: Chain A: L.19, H.20 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:H.20 GOL.3: 5 residues within 4Å: Chain A: H.76, N.131, P.132, Q.177, H.178 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:H.76, A:N.131, A:H.178

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Klemm, T. et al., Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2. Embo J. (2020)

Release Date

2020-06-17

Peptides

Non-structural protein 3: A
ISG15 CTD-propargylamide: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
E

B
F

Non-structural protein 3

ISG15 CTD-propargylamide

Related Entries With Identical Sequence